The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cdzygW
via IFTTT
Phase-III trial of Oxford vaccine to begin in Pune next week
The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cdzygW
via IFTTT
0 comments:
Post a Comment